Moreover, in mice, TGR5-mediated GLP-1 secretion promotes energy expenditure by the BAT and muscle tissues [128], thus reducing the risk of obesity-related NAFLD. Here, GPBAR1 is linked to metabolic dysfunction-associated steatotic liver disease.